CN104086655B - 胰淀素样融合蛋白及其编码基因与应用 - Google Patents
胰淀素样融合蛋白及其编码基因与应用 Download PDFInfo
- Publication number
- CN104086655B CN104086655B CN201310110871.4A CN201310110871A CN104086655B CN 104086655 B CN104086655 B CN 104086655B CN 201310110871 A CN201310110871 A CN 201310110871A CN 104086655 B CN104086655 B CN 104086655B
- Authority
- CN
- China
- Prior art keywords
- amylin
- fusion protein
- sample
- amino acid
- acid residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310110871.4A CN104086655B (zh) | 2013-04-02 | 2013-04-02 | 胰淀素样融合蛋白及其编码基因与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310110871.4A CN104086655B (zh) | 2013-04-02 | 2013-04-02 | 胰淀素样融合蛋白及其编码基因与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104086655A CN104086655A (zh) | 2014-10-08 |
CN104086655B true CN104086655B (zh) | 2019-02-15 |
Family
ID=51634438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310110871.4A Active CN104086655B (zh) | 2013-04-02 | 2013-04-02 | 胰淀素样融合蛋白及其编码基因与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104086655B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024022465A1 (zh) * | 2022-07-29 | 2024-02-01 | 杭州九源基因工程有限公司 | 一种人胰淀素多肽衍生物及其用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101400698A (zh) * | 2006-03-15 | 2009-04-01 | 诺沃-诺迪斯克有限公司 | 胰岛淀粉样多肽衍生物 |
CN101855240A (zh) * | 2007-09-11 | 2010-10-06 | 诺沃-诺迪斯克有限公司 | 改进的胰岛淀粉样多肽衍生物 |
CN101878036A (zh) * | 2007-11-29 | 2010-11-03 | 韩美药品工业株式会社 | 包含促胰岛素释放肽缀合物的治疗肥胖相关疾病的药物组合物 |
-
2013
- 2013-04-02 CN CN201310110871.4A patent/CN104086655B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101400698A (zh) * | 2006-03-15 | 2009-04-01 | 诺沃-诺迪斯克有限公司 | 胰岛淀粉样多肽衍生物 |
CN101855240A (zh) * | 2007-09-11 | 2010-10-06 | 诺沃-诺迪斯克有限公司 | 改进的胰岛淀粉样多肽衍生物 |
CN101878036A (zh) * | 2007-11-29 | 2010-11-03 | 韩美药品工业株式会社 | 包含促胰岛素释放肽缀合物的治疗肥胖相关疾病的药物组合物 |
Non-Patent Citations (1)
Title |
---|
周艳芳 等.精氨酸-甘氨酸-天冬氨酸肽类似物与新生血管内皮靶向治疗.《中国组织工程研究》.2012,第16卷(第43期),8111-8116. |
Also Published As
Publication number | Publication date |
---|---|
CN104086655A (zh) | 2014-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104327187B (zh) | 一种重组人GLP-1-Fc融合蛋白 | |
CN103957926B (zh) | 具有增强的作用持续时间和降低的免疫原性的工程改造的多肽 | |
CN103403019A (zh) | 具有增强的作用持续时间的工程化多肽 | |
BR112014029409B1 (pt) | Domínio de ligação a albumina isolado não natural, método para produção do mesmo, polinucleotídeo isolado, vetor isolado, célula hospedeira isolada, proteína de fusão e composição farmacêutica | |
CN107698684B (zh) | 包含突变的免疫球蛋白Fc部分的GLP-1融合蛋白 | |
US20190322717A1 (en) | High-activity long-acting hypoglycemic fusion protein as well as preparation method and medical application thereof | |
CN113265007B (zh) | 一种治疗代谢疾病的融合蛋白及其制备方法和应用 | |
US20210253662A1 (en) | Long-Acting Recombinant GLP1-Fc-CD47 Protein and Preparation and Use Thereof | |
US11746134B2 (en) | Human FGF21 mutant with improved effectiveness and stability and pharmaceutical composition thereof | |
CN110256575A (zh) | 一种长效重组人生长激素融合蛋白及其工程细胞 | |
CN102690352A (zh) | 含有glp-1的融合蛋白、其药物组合物及用途 | |
CN105254763B (zh) | 一种重组促胰岛素分泌素融合蛋白、制备方法及其应用 | |
CN106608915A (zh) | Glp-1(7-37)多肽类似物 | |
CN113880954A (zh) | 一种重组人生长激素及其构建方法和应用 | |
CN104086655B (zh) | 胰淀素样融合蛋白及其编码基因与应用 | |
CN113583142A (zh) | 双靶点融合蛋白、编码基因、载体或宿主细胞及其应用与表达和纯化方法 | |
CN110172103B (zh) | GLP-1类似物-Fc融合蛋白及其制备方法和用途 | |
CN109776653B (zh) | 一种人血清白蛋白黏附肽及其应用 | |
Reitinger et al. | High-yield recombinant expression of the extremophile enzyme, bee hyaluronidase in Pichia pastoris | |
CN104292341A (zh) | 一种凝血八因子融合蛋白及其制备方法和用途 | |
CN101863982A (zh) | 一种用于升高血小板的融合蛋白及其制备方法 | |
JP2013529900A (ja) | B細胞活性化因子の拮抗物質、その調製方法及び利用法 | |
WO2023035817A1 (zh) | 一种fgf21突变蛋白及其应用 | |
CN104277112A (zh) | 长效降血糖融合蛋白 | |
CN104870478A (zh) | 具有改善的药代动力学性质的治疗性多肽融合蛋白及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160317 Address after: 213025, Dongfang hi tech Industrial Park, No. 167 Dongfang Dong Road, Qishuyan District, Jiangsu, Changzhou Applicant after: CHANGZHOU BIOWIN BIOPHARM CO., LTD. Address before: 100085, C906, No. 9, 3rd Street, Beijing, Haidian District Applicant before: Beijing Kanghuayuan Technology Development Co., Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 213012 3rd floor, No. 3 Building, California Science and Technology Port, 218 Fumin Road, Changzhou City, Jiangsu Province Patentee after: Changzhou Bo Wen Di medical Limited by Share Ltd Address before: 213025 East High-tech Industrial Park No. 167 Dongfang East Road, Qishuyan District, Changzhou, Jiangsu Province Patentee before: CHANGZHOU BIOWIN BIOPHARM CO., LTD. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Amylin like fusion protein and its coding gene and Application Effective date of registration: 20220329 Granted publication date: 20190215 Pledgee: Jiangsu Jiangnan Rural Commercial Bank Limited by Share Ltd. Pledgor: CHANGZHOU BOWENDI PHARMACEUTICAL CO.,LTD. Registration number: Y2022320000147 |